EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Select your location
Local sites
Office
London, United Kingdom
Having joined EY in 1998, Pamela leads a team of 36,000 multidisciplinary professionals in the health and life sciences industries to share insight and knowledge. Working across the ecosystem, they understand the implications of today’s trends, proactively finding solutions to business issues and positioning clients to seize the upside of disruption in our transformative age.
Prior to her current role, she focused on cross-border transactions, providing deal advisory services including new commercial and risk and governance operating models. She has a background in organic chemistry.
How Pamela is building a better working world
Pamela is passionate about making healthcare affordable and accessible to all and helping to ensure we collectively maximize the opportunity to continually innovate in R&D. Critical to this is the industry to define, measure and design payment systems aligned to outcomes based performance rather the present ‘input and activity based’ systems. Increased computational power and AI, along with more demanding consumers, brings unparalleled opportunity for innovation and collaboration with disruptors to the traditional industry value chain.
“Strong data science and behavioral science as well as clinical and medicinal science capabilities will be critical for success.”
Pamela’s latest thinking
Innovation can utilize data for value-based care
Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future. Learn more.
20 Mar 2023
Pamela Spence
How you can create value in an intelligent health ecosystem
The intelligent health ecosystem will provide smarter insights and personalized health care experiences to patients, anytime and anywhere.
26 May 2022
Pamela Spence
How one entrepreneur seeks to make affordable health care a reality
Celltrion’s JungJin SEO shares his purpose and passion for more accessible health care. Learn more.
01 Mar 2022
EY Global
How data can help redesign the health experience
In this episode of the EY Health Sciences and Wellness Experience Podcast, Pamela Spence discusses the importance of data and how it can help redesign the health experience. Learn more.
21 Feb 2022
16m 52s
Health sciences wellness experience
Join EY panellists and guests, as they expand the traditional definitions of innovation to meet ever-growing needs and expectations.
08 Dec 2021
The age of ‘Health Experience’
In this first episode of our EY health sciences and wellness experience podcast, we explore the emerging age of “Health Experience.” Learn more.
16 Aug 2021
8m 0s
How the future of health care is becoming a reality
Human-centric care will soon become a reality, driven by data and technology.
22 Jun 2021
Pamela Spence
Foreign investors back Europe , but is Europe back?
COVID-19 caused a 13% decline in foreign investment in Europe. Swift action is needed to secure Europe’s long-term attractiveness. Find out more.
07 Jun 2021
Julie Teigland
As data personalizes medtech, how will you serve tomorrow’s consumer?
Medtech companies must evolve new business models that secure their role as a trusted partner in a dynamic, connected ecosystem.
03 Dec 2020
Pamela Spence
How an ‘accidental entrepreneur’ is on a mission to change capitalism
Biocon’s Dr. Kiran Mazumdar-Shaw shares how she overcame challenges to turn a US$500 investment into one of Asia’s leading biotech companies.
19 Oct 2020
EY Global
How biopharmas can create long-term growth focusing on sustainability
In health care, there is a growing need to embed the perspectives of diverse stakeholders in the sustainability agenda.
16 Oct 2020
Pamela Spence
How can Europe reset the investment agenda now to rebuild its future?
COVID-19 has slowed foreign investment in Europe, but there’s still cause for optimism, according to EY’s latest Attractiveness survey.
28 May 2020
Julie Teigland
Five trends driving the emergence of the personalized health ecosystem
As health care becomes more data-driven, we explore how organizations can contribute to a personalized health ecosystem.
28 Apr 2020
Pamela Spence
How will deals done now deliver what the health ecosystem needs next?
In the 2020 EY M&A Firepower report, EY explores how life sciences companies can use dealmaking now to tackle what is coming next.
12 Jan 2020
Pamela Spence
How we can place a value on health care data
Estimating the value of patient data and unlocking that value in the UK’s National Health Service can help fuel health care innovation.
19 Jul 2019
Pamela Spence
How Life Sciences 4.0 is fusing the digital and biological worlds
At EY, we’re committed to creating a better working world and also a much healthier one.
29 Mar 2019
Pamela Spence
How seamless, secure sharing of data is essential to improve health outcomes
Platform-enabled businesses will take full advantage of the proliferation of health data to deliver better outcomes to people
14 Mar 2019
Pamela Spence